Sepsis in Solid-Organ Transplant Patients.

Area of Science:

• Transplant Medicine
• Infectious Diseases
• Critical Care

Background:

• Solid organ transplant (SOT) recipients have a heightened susceptibility to infections.
• Sepsis in SOT recipients can present with atypical symptoms, including reduced fever and leukocytosis.
• Infections are a significant threat to allograft and patient survival in SOT recipients.

Purpose of the Study:

• To review the unique challenges in managing sepsis in SOT recipients.
• To highlight the atypical clinical presentation of sepsis in this population.
• To discuss current management strategies and the impact on SOT outcomes.

Main Methods:

• Literature review of sepsis management in SOT recipients.
• Analysis of clinical presentations and diagnostic challenges.
• Evaluation of treatment protocols, including fluid resuscitation and immunosuppression management.

Main Results:

• SOT recipients with sepsis often exhibit attenuated signs and symptoms compared to non-transplanted patients.
• Fluid management is critical, as fluid overload can be detrimental.
• The optimal approach to immunosuppressive therapy during sepsis remains debated, with dose reduction or withdrawal being considered.

Conclusions:

• Sepsis management in SOT recipients requires tailored approaches, considering their unique physiology and immunosuppression.
• Early recognition and prompt, appropriate treatment are crucial for improving survival.
• The outcomes of sepsis in SOT recipients are being re-evaluated, challenging previous assumptions of universally worse prognosis.